ScreenerHero

SNT Synektik Spólka Akcyjna

GPW · PL · Healthcare · Medical Devices · synektik.com.pl
342.80PLN+0.35%Mkt Cap: 737.89M $P/E: 16.34

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$170.98BUSDP/E 31.7
MDT
Medtronic plc
$111.40BUSDP/E 21.4
SYK
Stryker Corporation
$106.71BUSDP/E 28.8
BSX
Boston Scientific Corporation
$61.14BUSDP/E 17.1
EW
Edwards Lifesciences Corporation
$49.80BUSDP/E 51.5
SHL
Siemens Healthineers AG
$46.31BUSDP/E 19.3
DXCM
DexCom, Inc.
$31.47BUSDP/E 33.1
GEHC
GE HealthCare Technologies Inc.
$29.46BUSDP/E 14.9
PHIA
Koninklijke Philips N.V.
$22.91BUSDP/E 18.7
PHG
Koninklijke Philips N.V.
$23.60BUSDP/E 18.0
STE
STERIS plc
$20.34BUSDP/E 25.5
SOON
Sonova Holding AG
$17.13BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$17.11BUSDP/E 21.8
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
TXG
10x Genomics, Inc.
$10.51BUSD
GMED
Globus Medical, Inc.
$10.26BUSDP/E 19.6
DEMANT
Demant A/S
$9.97BUSDP/E 28.3
BIO
Bio-Rad Laboratories, Inc.
$9.87BUSDP/E 46.7
GKOS
Glaukos Corporation
$9.53BUSD

Key Statistics

Company
Market Cap737.89M USD
Enterprise Value728.84M USD
Revenue (TTM)236.28M USD
Gross Profit61.68M USD
Net Income (TTM)26.07M USD
Revenue/Share109.39 PLN
Last Price342.80 PLN
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees231
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLSNKTK00019
Valuation
P/E (Trailing)16.34
P/E (Forward)28.71
PEG—
EV/EBITDA12.09
EV/Revenue3.08
P/S3.12
P/B13.60
EPS (TTM)20.80
EPS (Forward)11.90
52W Range
198.3076% of range388.00
52W High388.00 PLN
52W Low198.30 PLN
Profitability
Gross Margin35.73%
Oper. Margin22.63%
EBITDA Margin25.52%
Profit Margin15.10%
ROE46.04%
ROA21.04%
Growth
Revenue Growth89.50%
Earnings Growth132.40%
Cash Flow & Leverage
Operating CF19.83M USD
CapEx (TTM)4.42M USD
FCF Margin14.18%
FCF Yield4.54%
Net Debt-9.05M USD
Net Debt/EBITDA-0.15
Balance Sheet
Debt/Equity0.18
Current Ratio1.46
Quick Ratio1.21
Book Value/Sh25.11 PLN
Cash/Share9.06 PLN
Dividends
Fwd Div Rate10.75 PLN
Trail. Div Rate10.75 PLN
Div. Yield3.15%
5Y Avg Yield1.64%
Payout Ratio51.68%
Ex-Div DateJan 28, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)373.00 PLN
Upside (mean)+8.8%
Target Range323.00 PLN – 419.00 PLN
323.00+8.8% to mean419.00
# Analysts5
Ownership
Shares Out.8.53M
Float7.00M
Insiders16.79%
Institutions17.07%
Technical
SMA 50348.75 (-1.7%)
SMA 200311.94 (+9.9%)
Beta0.42
S&P 52W Chg14.58%
Avg Vol (30d)48.83K
Avg Vol (10d)24.21K
Technical Indicators
RSI (14)56.1
MACD11.6573
MACD Signal13.7086
MACD Hist.-2.0513
BB Upper382.58 PLN
BB Middle341.04 PLN
BB Lower299.50 PLN
BB Width24.36%
ATR (14)12.87 PLN
Vol Ratio (20d)0.57x